OwlMed is currently entering into collaborative agreements with major UK companies specializing in design and construction of RFID, and signal analysis and pattern recognition techniques. Active support and engagement of University experts and cardiovascular clinical specialists will progress the development of the instrumented valve through pre-clinical and clinical evaluation to regulatory approval and the market.